Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 5/20 | 0.33 |
| ▸ | FNTB | P49356 | 5/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29461527 | 0.95 | MME (0.39) | MMEACE | |
| SCHEMBL30287540 | 0.93 | ACE (0.38) | MMEACEFNTAFNTBPGGT1B | |
| SCHEMBL30477907 | 0.93 | FNTA (0.38) | MMEACEFNTAFNTBPGGT1B | |
| SCHEMBL30477913 | 0.93 | FNTA (0.38) | MMEACEFNTAFNTBPGGT1B | |
| SCHEMBL30477914 | 0.93 | FNTA (0.38) | MMEACEFNTAFNTBPGGT1B | |
| SCHEMBL28806216 | 0.93 | ACE (0.38) | MMEACEFNTAFNTBPGGT1B | |
| SCHEMBL30477919 | 0.93 | FNTA (0.38) | MMEACEFNTAFNTBPGGT1B | |
| SCHEMBL29630312 | 0.93 | MME (0.34) | MME | |
| SCHEMBL30272502 | 0.93 | MME (0.34) | MME | |
| SCHEMBL29777856 | 0.92 | MME (0.39) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12104362-B1 | Assessing and remediating well clogging from bacteria, systems, apparatuses, and methods | SEVEE & MAHER ENGINEERS, INC. (US) | 2024-10-01 | — | — | US | claimed |
| CN-112094316-B | High-zinc-chelating-activity zinc chelating peptide with Ser and Cys arranged at two ends and application thereof | 安徽省农业科学院农产品加工研究所 | 2022-04-08 | — | — | CN | claimed |
| US-12421698-B1 | Systems, apparatuses, and methods for changing a primary extraction location from an aquifer utilizing a custom extended pump sleeve (CEPS) | SEVEE & MAHER ENGINEERS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-12287271-B1 | Assessing and remediating well clogging from mobile particles, systems, apparatuses, and methods | SEVEE & MAHER ENGINEERS, INC. (US) | 2025-04-29 | — | — | US | disclosed |
| US-12270962-B1 | Specific capacity measurement and estimation in a well, systems, apparatuses, and methods | SEVEE & MAHER ENGINEERS, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | CALICO LIFE SCIENCES LLC (US) | 2025-03-06 | — | — | US | disclosed |
| US-12104362-B1 | Assessing and remediating well clogging from bacteria, systems, apparatuses, and methods | SEVEE & MAHER ENGINEERS, INC. (US) | 2024-10-01 | — | — | US | disclosed |
| CN-116873905-A | Method for separating long carbon nanotubes and short carbon nanotubes | 中国科学院物理研究所 | 2023-10-13 | — | — | CN | disclosed |
| CN-112094316-B | High-zinc-chelating-activity zinc chelating peptide with Ser and Cys arranged at two ends and application thereof | 安徽省农业科学院农产品加工研究所 | 2022-04-08 | — | — | CN | disclosed |
| CN-112094316-B | High-zinc-chelating-activity zinc chelating peptide with Ser and Cys arranged at two ends and application thereof | 安徽省农业科学院农产品加工研究所 | 2022-04-08 | — | — | CN | disclosed |
| CN-111909238-B | High-zinc-chelation-activity zinc chelating peptide containing Ser-Cys and application thereof | 安徽省农业科学院农产品加工研究所 | 2022-04-08 | — | — | CN | disclosed |
| CN-111925411-B | Cys-Ser-containing high-zinc-chelating-activity zinc chelating peptide and application thereof | 安徽省农业科学院农产品加工研究所 | 2022-04-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | MICA, CD74, HLA-DRB1 | MME 130/4885ACE 2383/4885FNTA 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.